CMP or PFPS: what the distinction actually means

'If my doctor says I have chondromalacia, does that mean my cartilage is actually damaged?' The short answer is: only if the diagnosis has been properly confirmed. The longer answer is where most of the confusion begins.

Two terms circulate around anterior knee pain — patellofemoral pain syndrome (PFPS) and chondromalacia patellae (CMP) — and they are not the same thing, even though older clinical literature frequently used them as synonyms.

PFPS is a pattern of symptoms: pain at the front of the knee brought on by activities such as stair climbing, squatting, or sitting for extended periods. It reflects biomechanical overload, muscle imbalance, or patellar maltracking. The cartilage itself may be entirely intact. Diagnosis rests on history and physical examination; imaging is typically normal and is not required to reach the diagnosis.

CMP, by contrast, is a structural finding — actual softening, fissuring, or degeneration of the hyaline cartilage on the underside of the kneecap. It must be demonstrated objectively, either on MRI or at arthroscopy. A symptom history alone cannot confirm it.

Three situations arise in practice: a patient may have PFPS with no cartilage damage; CMP with surprisingly few symptoms; or both together. That overlap is the main source of misdiagnosis.

The distinction carries real clinical weight. Without confirmation that cartilage damage exists, there is nothing to grade — and grading is what determines how treatment is planned. The sections that follow explain how that confirmation is reached.

What the clinical examination can and cannot tell you

In the consulting room, a recognisable pattern emerges. Anterior knee pain that worsens on stair climbing, squatting, or sitting for long periods — the so-called theatre sign — combined with crepitus when the kneecap is compressed, points towards the patellofemoral joint. Pain on resisted knee extension adds to that picture.

Clarke's test formalises this suspicion: the examiner applies gentle pressure across the top of the kneecap while the patient briefly contracts their quadriceps. Pain or grinding may reproduce the patient's complaint, but the test's standalone reliability is modest. Importantly, it cannot confirm that cartilage is damaged, nor can it grade how far any damage extends. A positive Clarke's test and a confirmed chondromalacia lesion are not the same thing.

That limitation applies to clinical examination as a whole. Neither symptom history nor physical tests can reliably distinguish PFPS — where the cartilage is structurally intact — from CMP, where it is not. Examination raises suspicion and determines whether imaging is warranted; it does not deliver the diagnosis.

In specialist settings, isokinetic dynamometry can add a functional dimension — and it bridges usefully to understanding why imaging matters. Research shows that CMP patients produce significantly lower quadriceps peak torque at 60°/s than unaffected individuals, with greater variability and a slower time to reach full force output. In plain terms, the affected leg is less consistent and slower to generate strength. This documents the functional deficit, but it does not confirm structural damage. For that, imaging takes over.

MRI and why sequence choice matters

MRI is the standard next step once examination raises a genuine suspicion of cartilage damage. Unlike X-ray, it produces detailed images of soft tissue — capturing signal change within the cartilage, surface fraying, focal fissuring, and in more advanced cases, full-thickness loss through to the underlying bone — all without radiation or surgical access.

Not all MRI scans are equally capable of showing this, however. Sensitivity and specificity depend heavily on which imaging sequence the scanning centre uses, and this has direct consequences for what gets picked up and what gets missed.

Fat-suppressed proton density sequences are the current benchmark. The PD-SPAIR sequence achieves a sensitivity of 86.7% and specificity of 93.5% against arthroscopy as the reference standard; 2D fat-suppressed PD (FS-PD) reaches diagnostic accuracy of 92–94% in comparative studies. Standard (non-fat-suppressed) proton density sequences perform noticeably less well — sensitivity closer to 70% and specificity around 77% — meaning earlier or subtler lesions are more likely to be missed.

The most demanding scenario is an early Grade 1 lesion: signal change within the cartilage where the surface itself still looks intact. No current MRI sequence reliably detects all of these. A scan reported as normal does not rule out early cartilage change; it may simply reflect the limits of the protocol used.

Patients attending for assessment are well-served by knowing this: what a radiology report can say depends partly on how the scan was acquired.

How cartilage damage is classified once found

Once a lesion is confirmed — whether on MRI or at arthroscopy — its severity is expressed as a grade, and that grade drives the treatment conversation directly.

The Outerbridge classification, developed for use at arthroscopy, remains the reference framework. Grade 0 is normal cartilage. Grade I describes softening or swelling where the surface is still intact. Grade II marks the point where the surface breaks down — partial-thickness fissuring involving less than half the cartilage depth. Grade III extends deeper than 50%, producing the characteristic 'crab-meat' fraying seen in more advanced cases. Grade IV is full-thickness loss, with bare subchondral bone exposed beneath.

MRI grading maps closely onto this scheme. Grade 1 is a signal change within an architecturally intact surface — the earliest and hardest-to-detect finding, as noted in the previous section. Grades 2 through 4 reflect the same progression of depth as the arthroscopic scale, with Grade 4 additionally showing marrow oedema in the underlying bone.

At Grade 3, a more detailed sub-classification (3A through 3D) tracks how far the lesion extends relative to the calcified cartilage layer. This level of granularity matters primarily when cartilage restoration procedures are being planned.

Lesion area is a second, independent dimension. A defect smaller than 2 cm² opens different treatment options than one in the 2–4 cm² range; depth and size together determine what is feasible.

One point deserves emphasis: grade and symptoms do not always align. Some patients with Grade 3 or 4 changes report little pain, while others with Grade 1–2 findings are significantly limited. Grade informs what the cartilage looks like — not how much it hurts.

When arthroscopy is needed to settle the diagnosis

Arthroscopy — passing a small camera directly over the patellar cartilage surface — is the only method that allows a surgeon to both visualise and physically probe the tissue. Firmness, texture, and the precise extent of any fissuring can be assessed in real time, and the Outerbridge grades applied under direct vision rather than inferred from imaging signal. That directness is why arthroscopy remains the reference standard against which MRI sequences are measured.

In practice, diagnostic arthroscopy for chondromalacia alone is uncommon. The procedure carries anaesthesia, a recovery period, and a small but genuine complication risk — and for most patients, a high-quality MRI using fat-suppressed sequences, interpreted alongside the clinical picture, gives enough information to plan initial management without a surgical step.

Two situations genuinely justify the escalation. The first is diagnostic uncertainty: where MRI findings are equivocal and clinical suspicion stays high, direct inspection resolves what imaging cannot (the limitations of even the best sequences for subtle lesions are covered in section 3). The second is therapeutic logic — when chondroplasty or cartilage repair is already being considered, grading under direct vision at the same sitting is practical rather than duplicative.

The decision is made jointly between patient and specialist, weighing the information gain against the procedural burden. For most people with anterior knee pain and a well-acquired scan, that threshold is not reached.

The anatomical and biomechanical picture

Cartilage does not wear away randomly. The pattern of breakdown on the underside of the patella is shaped by how the kneecap moves through its groove — and that mechanical picture is as clinically important as the lesion grade itself.

Several measurements bring this into focus. The tibial tubercle–trochlear groove (TTTG) distance quantifies how far the kneecap's attachment point is offset from the groove centre; values above roughly 20 mm suggest maltracking, with contact force concentrated on a narrower area than the joint was designed to absorb. Trochlear depth, patellar tilt, Q-angle, and lower limb alignment — including foot pronation and knee valgus — complete the picture of how load arrives at the patellofemoral surface.

Quadriceps strength, particularly the vastus medialis oblique (VMO), sits at both ends of this chain. Weakness allows the patella to drift laterally, increasing focal pressure; pain then inhibits the muscle further, so the deficit compounds over time. Isokinetic testing can document this objectively when clinical examination alone leaves the degree of functional impairment unclear.

These findings explain why two patients with identical Outerbridge Grade 3 lesions may follow quite different management paths. Where an elevated TTTG is the primary driver, any plan must address the tracking problem alongside the cartilage surface itself; where muscle imbalance and loading patterns dominate, rehabilitation targets are framed differently. Structural grade, lesion area, and biomechanical profile are three separate axes — all of which the specialist weighs together before arriving at the right course of action.

1. [1] Patellofemoral pain syndrome. https://en.wikipedia.org/?curid=12033023 https://en.wikipedia.org/?curid=12033023
2. [2] Chondromalacia patellae. https://en.wikipedia.org/?curid=1944613 https://en.wikipedia.org/?curid=1944613
3. [3] Comparative analysis of isokinetic parameters in individuals with and without chondromalacia patellae. (2025). https://doi.org/10.1016/j.jisako.2024.100383 https://doi.org/10.1016/j.jisako.2024.100383
4. [4] Comparison of 2D FS-PD and 3D WATS-c MRI sequences in evaluation of chondromalacia patellae. (2019). https://doi.org/10.1186/s43055-019-0102-z https://doi.org/10.1186/s43055-019-0102-z
5. [5] Diagnosis and Grading of Chondromalacia of Patella using Axial PD-SPAIR and Axial PD MRI Sequences. (2025). https://doi.org/10.59324/ejmhr.2025.3%284%29.27 https://doi.org/10.59324/ejmhr.2025.3%284%29.27